Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

Clinical trial NCT06034275 · RECRUITING

Trial details

NCT number: NCT06034275
Sponsor: Vincerx Pharma, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia B-cell Acute Lymphoblastic Leukemia High-risk Myelodysplastic Syndrome

Start date: 2023-09-13
Primary completion: 2025-05-30
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.